Brief: Lanxess Exercises Right To Offer For The Sale Of Its Shares In Envalior In 2026

LANXESS AG

23/09/2025 13:02

Sept 23 (Reuters) - Specialty chemicals maker Lanxess LXSG.DE on Tuesday said it would offer to sell all its shares in Envalior to its joint venture partner, an investment company of Advent International.

Lanxess said in a statement it had agreed to a base purchase price of around 1.2 billion euros ($1.42 billion) for the tendered shares.

"If and to what extent the share sale will be completed will be known by March 2026 at the latest," the company said.

($1 = 0.8478 euros)

 (Reporting by Ozan Ergenay in Gdansk, Editing by Rachel More)

 ((Ozan.Ergenay@thomsonreuters.com;))